Month: May 2021

Oslo, Norway – 12 May 2021 – IDEX Biometrics ASA, a leading provider of advanced fingerprint identification and authentication solutions, has prepared an updated Company Presentation for the first quarter of 2021. The presentation is attached, as a PDF file, at the end of this release. The presentation is also available at: https://www.idexbiometrics.com/investors/events-presentations/ For further information contact:Marianne Bøe, Investor Relations E-mail: marianne.boe@idexbiometrics.com Tel: +47 918 00186 Brett L. Perry, U.S. Investor RelationsE-mail: bperry@sheltongroup.comTel: +1 214 272 0070 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal touch-free authentication for all.  We help people make payments,...

VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company announces that NP-120 (Ifenprodil) reduced interleukin 6 (IL-6) with statistical significance in its recent Ifenprodil Phase 2b/3 COVID-19 trial, which may be informative for the Company’s ongoing Phase 2 trial of Ifenprodil for idiopathic pulmonary fibrosis (IPF) and chronic cough. The Company reports that in the COVID-19 trial, one of the biomarkers that was measured was the change in IL-6 levels. In the measurement from baseline to day five, IL-6 was reduced in the 20 mg treatment arm by 267 ng/L, versus 7 ng/L in the standard of care arm (values are adjusted mean concentrations; p = 0.0292). IL-6 acts as both a pro-inflammatory...

  No. 9/2021 Copenhagen, 12 May 2021 Closing of sale Referring to our Company announcement no 7 of 26 April 2021 we hereby inform that the Carve-out Sale of Lauritz.com A/S’ subsidiaries in Sweden, Germany and Finland, including AB Stockholms Auktionsverk, has now be closed and thereby finalized. Change in reporting calendar With reference to the extension of the deadline for filing the annual report for 2020 (L225 approved by the danish parliament on 11 May 2021) we make the following changes to our reporting calendar:31 May 2021: Annual report 2020 The Annual General Meeting will be held in Copenhagen on 22 June 2021, 11 am. Best regards Lauritz.com Group A/S Bengt Sundström Chairman    For press enquiries, please contact: Mette Jessen, E-mail press@lauritz.com    Certified Adviser: Erik Penser Bank AB Telephone number: +46...

Studies show location accuracy and tolerability of the novel oral Drug Delivery System (DDS) and point to a materially enhanced therapeutic/safety index for PGN-600 SAN DIEGO, May 12, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced preliminary results, subject to final audited study reports by its contract research organization (CRO), from two key studies for the Company’s Targeted Therapeutics program. The studies involved both the first functional clinical study of the Drug Delivery System (DDS), and the first preclinical study of PGN-600 (liquid tofacitinib delivered by DDS), one of the Company’s drug/DDS combination products. Progenity’s Targeted Therapeutics program consists of drug device combination products that allow the delivery of high concentrations of proprietary...

STOCKHOLM, SWEDEN – May 12, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that its portfolio company OssDsign completed a successful rights issue of shares with preferential rights for the company’s existing shareholders to a value of SEK 240 million. The rights issue was oversubscribed, to a rate of 185%, and thus the Board of Directors decided to carry out a directed new issue of shares without preferential rights for existing owners through an over-allotment option adding an additional SEK 30 million to the company. Due to the fact that the rights issue was oversubscribed, no guarantee commitments needed to be realized. A total of SEK 270 million were raised excluding transactions costs. In connection to the decision to conduct a rights issue, at the beginning of March this year, OssDsign presented a...

Reference is made to press release dated 15 April 2021 in which Prosafe informed that the Gulating Court of Appeal had decided that Prosafe had to pay Westcon the full amount claimed by Westcon. The Gulating Court of Appeal decided that Prosafe had to pay Westcon NOK 302,510,457 plus interest and legal costs, in total about NOK 465 million related to the conversion of the Safe Scandinavia at Westcon yard. This was a complete reversal of the result in the first instance by the Stavanger District Court, where Westcon was sentenced to pay Prosafe NOK 344 million plus interest and NOK 10.6 million in legal costs. Prosafe has decided to address the shortcomings of the judgement by the Gulating Court of Appeal through an appeal to the Supreme Court. Prosafe is a leading owner and operator of semi-submersible accommodation vessels. The company...

CALGARY, Alberta, May 12, 2021 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) today announced that Bill Tempany, Interim CEO, and Alana Forbes, CFO, will present virtually at the Q2 Investor Summit on Tuesday, May 18, 2021, at 11:45 AM ET (9:45 AM MT). Management of FLYHT will also be available for one-on-one meetings with investors throughout the two-day event.DATE: Tuesday, May 18, 2021   TIME: 11:45 AM ET (9:45 AM MT)   LINK: https://zoom.us/webinar/register/WN_5ogHcSbtR0m2SSAOKvv1AQAn archived webcast of the presentation will be made available at www.investorsummitgroup.com and in the Investors section of the FLYHT website at www.flyht.com/investors. For additional information or to schedule a meeting with FLYHT management, please register for the conference...

Silence Therapeutics to Participate in Fireside Chat at the RBC Capital Markets Global Healthcare Conference 12 May 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced the Company will participate in a fireside chat at the virtual RBC Capital Markets Global Healthcare Conference on Wednesday, May 19th at 8:35 a.m. ET / 1:35 p.m. BST A live webcast of the presentation can be accessed via the Investors section of Silence’s website at www.silence-therapeutics.com. An archived replay of the webcast will be available on the Company’s website following the conference. Enquiries:Silence Therapeutics...

Plc Uutechnic Group Oyj    Stock exchange release      12 May 2021 at 2:00 p.m. EET Plc Uutechnic Group Oyj applies for delisting of its shares from Nasdaq Helsinki The board of directors of Plc Uutechnic Group Oyj (“UTG”) has decided to apply for the termination of public trading in UTG’s shares and for delisting of UTG’s shares from the official list of Nasdaq Helsinki Ltd (“Nasdaq Helsinki”). SPX FLOW Technology Germany GmbH (“SPX FLOW”) owns more than nine-tenths (9/10) of all shares and voting rights in UTG and has therefore initiated arbitration proceedings in accordance with Chapter 18 of the Finnish Companies Act (the “Companies Act”) in order to redeem all the remaining shares in UTG held by the minority shareholders. SPX FLOW has requested the arbitral tribunal appointed...

Millicom First to bring innovative O-RAN compliant Open RAN to Latin America Partners with Parallel Wireless for the deployment Millicom subsidiary TIGO Colombia to deliver service with 362 rural sites Luxembourg, May 12, 2021 – Millicom will become the first operator in Latin America to deploy O-RAN compliant Open Radio Access Network (Open RAN) architecture in partnership with Parallel Wireless. The innovative technology will be deployed by Millicom’s subsidiary Tigo Colombia, delivering 4G service coverage with 362 rural sites. Open RAN is the disaggregation of hardware and software components so that one supplier’s software can be integrated with another supplier’s radio and commercial-off-the-shelf (COTS) server hardware. This open architecture paves the way for faster mobile coverage roll-out to remote rural areas. By taking this...